CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

You are correct that there is underreporting of adverse effects from vaccines; however, in the vast majority of cases, the ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.